Evidence map›Paper›PMID 26377420›Full record

ArticleLipids in health and disease2015

Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men.

Jeannette Salgado-Montilla, Marievelisse Soto Salgado, Barbara Surillo Trautmann, Ricardo Sánchez-Ortiz, Margarita Irizarry-Ramírez

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Serum lipids and prostate cancer.Journal of clinical laboratory analysis · 2021
    Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Impact of FTO SNPsArchives in cancer research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jeannette Salgado-MontillaUPR/MDACC Partnership in Excellence in Cancer Research Program, Medical Sciences Campus, University of Puerto Rico, PO Box 365067, San Juan, 00936-5067, Puerto Rico. jeannette.salgado@upr.edu.
Marievelisse Soto SalgadoUPR/MDACC Partnership in Excellence in Cancer Research Program, Medical Sciences Campus, University of Puerto Rico, PO Box 365067, San Juan, 00936-5067, Puerto Rico. marievelisse.soto1@upr.edu.
Barbara Surillo TrautmannGraduate Department, Clinical Laboratory Sciences, School of Health Professions, Medical Sciences Campus, University of Puerto Rico, PO Box 365067, San Juan, 00936-5067, Puerto Rico. barbara.surillo@upr.edu.
Ricardo Sánchez-OrtizUrology Section, School of Medicine, Medical Sciences Campus, University of Puerto Rico, PO Box 365067, San Juan, 00936-5067, Puerto Rico. drsanchezortiz@gmail.com.
Margarita Irizarry-RamírezGraduate Department, Clinical Laboratory Sciences, School of Health Professions, Medical Sciences Campus, University of Puerto Rico, PO Box 365067, San Juan, 00936-5067, Puerto Rico. margarita.irizarry@upr.edu.
University of Puerto Rico, Medical Sciences Campus · PRUniversity of Puerto Rico System · PR

Funding

UPR/MDACC Partnership for Excellence in Cancer Research(Parent Grant U54 CA096297)U54CA096297 · NCI · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI Ilka C Rios · 2002 to 2026
$36.9M
UPR/MDACC Partnership for Excellence in Cancer Research (Luis Segarra supplement)U54CA096300 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Larkin Strong · 2002 to 2026
$23.8M
TECHNOLOGIES AND RESOURCES FOR CORE LABORATORIESU54MD007587 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI LUCIANO, CARLOS A., WOJNA, VALERIE · 2012 to 2018
$23.2M
NCI NIH HHS CA096297/CA096300NCI NIH HHS U54 CA096297NCI NIH HHS U54 CA096300NIMHD NIH HHS 8U54MD007587NIMHD NIH HHS U54 MD007587
6 · The paper itself

Abstract

backgroundWhile obesity and fat intake have been associated with an increased risk of prostate cancer (PCa) aggressiveness and mortality, the association between lipid levels and PCa phenotype remains unclear. Previous reports evaluating this association are inconsistent and highly variable when considering different racial/ethnic groups. There are scarce data regarding this association among Hispanics, and specifically Puerto Rico's Hispanic men, a population with a higher burden of PCa, metabolic syndrome and overweight. This population has a different ancestry profile than other Hispanics from Central and South America. Due to the above the researchers inquired if there is a relationship between serum lipid levels and PCa phenotype in this understudied population using a cohort of patients treated with radical prostatectomy as their first treatment.

methodsWe performed an exploratory retrospective medical record review study of 199 PCa patients who underwent radical prostatectomy between 2005 and 2012. Variables analyzed included age at PCa diagnosis, Body Mass Index (BMI), preoperative serum prostate-specific antigen (PSA), lipid levels, and clinical parameters such as prostatectomy pathologic stage and Gleason Score (GS). PCa severity was defined using pathologic stage and GS. Unadjusted and adjusted logistic regression models were fitted to estimate the odds ratios (ORs) with 95 % confidence intervals (CI) to define the relationship among clinical characteristics and PCa severity.

resultsMean age for the cohort was 58.8 years (range: 40-75), 78.9 % were overweight or obese, 36.7 % had hypertriglyceridemia, and 35.2 % had low HDL levels. In the unadjusted logistic regression model, hypertriglyceridemia (OR: 2.11, 95 % CI = 1.13-3.93), low HDL (OR: 1.90, 95 % CI = 1.02-3.56-), and age (OR: 2.34, 95 % CI 1.25-4.40) were significantly associated with a diagnosis of high severity of PCa.

conclusionsIn Puerto Rican men with PCa, elevated hypertriglyceridemia, low HDL levels, and age were statistically associated with high grade PCa on bivariate analysis. Total cholesterol level was not associated with severity of disease. Associations lost significance upon multivariate adjustment. These data generate important hypotheses regarding the potential relationship between lipid pathways and PCa development and underscore the need to perform larger scale and longitudinal studies to sort out whether, hypertriglyceridemia is associated with PCa phenotype and development.

Indexed as

AdultAgedBody Mass IndexCholesterol, HDLHispanic or LatinoHumansHypertriglyceridemiaMaleMetabolic SyndromeMiddle AgedNeoplasm GradingNeoplasm StagingObesityOdds RatioProstateProstatectomyCholesterol, HDLProstate-Specific AntigenTriglycerides

Identifiers

PMID26377420
PMCPMC4574177
OpenAlexW1918319984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.